Conferences
Conference Details
Sponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase 2 proof-of-concept and dose range finding studies are vital to effectively designing future registration studies
Date :
Place : United States, Philadelphia
Contact Person:Paula Edwards
Description:
Sponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase 2 proof-of-concept and dose range finding studies are vital to effectively designing future registration studiesSponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase 2 proof-of-concept and dose range finding studies are vital to effectively designing future registration studies will be held in Philadelphia,United States on date 2017-10-20
Deadline for abstracts/proposals : 5th October 2017
Organized By :New York Events List
Keynote Speakers :
Conference Highlights :Implement adaptive study designs and predictive models to successfully accelerate early phase trials Improve vendor identification and communication from negotiation to study execution Overcome the evolving challenges of patient recruitment and retention for different diseases
Venue :Philadelphia, PA 19104, United States
Check the event website for more details.
Views:
754